Summarized by Masters of Longevity from Longevity Technology.
Phase 1 human data and mouse studies showed increased cellular energy use.

Key Takeaways
- ATX-304 is an oral AMPK network activator that boosts energy use.
- Phase 1 human data showed initial pharmacology and tolerability signals.
- Mouse studies suggested muscle sparing, but human confirmation remains unproven.



